SOPHiA GENETICS
SOPH
32 hedge funds and large institutions have $86.3M invested in SOPHiA GENETICS in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 6 closing their positions.
10% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 10
6% more capital invested
Capital invested by funds: $81.4M → $86.3M (+$4.87M)
0.22% more ownership
Funds ownership: 26.59% → 26.81% (+0.22%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
11% less funds holding
Funds holding: 36 → 32 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AKRE Capital Management
Middleburg,
Virginia
|
+$1.39M |
| 2 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$671K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$646K |
| 4 |
MSAM
Moloney Securities Asset Management
Manchester,
Missouri
|
+$453K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$262K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
-$1.34M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$386K |
| 3 |
Millennium Management
New York
|
-$324K |
| 4 |
Morgan Stanley
New York
|
-$220K |
| 5 |
PFM
Privium Fund Management
Amsterdam,
Netherlands
|
-$140K |
SOPH Hedge Fund Activity: Q1 2024 in Review
32 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q1 2024, worth a combined $86.3M — up 6% from $81.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of SOPH and 2 opened new positions — a net loss of 4 holders — while 10 trimmed existing stakes and 11 added.
The largest buyer was AKRE Capital Management, opening a new position worth an estimated $1.39M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $1.34M sold.
- 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q1 2024, down from 36 in Q4 2023.
- Funds reported $86.3M of SOPHiA GENETICS stock for Q1 2024, up 6% quarter-over-quarter.
- 2 funds opened new SOPHiA GENETICS positions in Q1 2024 and 6 closed out, a net change of -4 holders.
- The largest SOPHiA GENETICS buyer in Q1 2024 was AKRE Capital Management, an estimated $1.39M added.
- The largest SOPHiA GENETICS seller in Q1 2024 was Pura Vida Investments, an estimated $1.34M sold.
Based on aggregated 13F filings for Q1 2024.